GIM
LLY icon

Glenmede Investment Management’s Eli Lilly LLY Stock Holding History

Glenmede Investment Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$240M Buy
314,370
+3,412
+1% +$2.54M 1.16% 15
2025
Q2 		$242M Buy
+310,958
New +$242M 1.23% 10

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Glenmede Investment Management's LLY Position: Q3 2025 in Review

Glenmede Investment Management increased its Eli Lilly (LLY) stake by 1.1% in Q3 2025, buying an estimated $2.54M and bringing the position to 314,370 shares worth $240M. The position accounts for 1.16% of the portfolio, ranked #15.

Glenmede Investment Management first reported a position in LLY in Q2 2025 and has held it in 2 quarters since. The position peaked at $242M in Q2 2025. 3,897 funds tracked by Wall St. Rank hold LLY as of Q3 2025.

  • Glenmede Investment Management held 314,370 shares of Eli Lilly worth $240M as of Q3 2025.
  • Glenmede Investment Management bought 3,412 Eli Lilly shares in Q3 2025, an estimated $2.54M.
  • Eli Lilly made up 1.16% of Glenmede Investment Management's portfolio in Q3 2025, its #15 holding.
  • Glenmede Investment Management first reported a position in Eli Lilly in Q2 2025 and has held it in 2 quarters since.
  • Glenmede Investment Management's Eli Lilly position peaked at $242M in Q2 2025.
  • 3,897 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2025.

Based on Glenmede Investment Management's 13F filing for Q3 2025, filed 13 Nov 2025.